Mavacoxib CAS 170569-88-7 GMP Anti- Inflammatory Series

Mavacoxib CAS 170569-88-7 GMP Anti- Inflammatory Series. GMP Manufacturing: Produced under strict GMP conditions with Class 100 to 100,000 cleanrooms. Veterinary Application: Approved for treating pain and inflammation in dogs with degenerative joint disease. Long-Acting Inhibition: Selective COX-2 inhibitor with a plasma half-life of up to 80 days in dogs. Customizable Packaging: Packaging available in 10mg, 25mg, 1g, 10g, 25kg to meet research needs. FDA Inspections Passed: Successfully passed 6 consecutive US FDA inspections ensuring quality standards. Global Logistics: Standardized moisture-proof packaging with timely delivery and smooth customs clearance. Comprehensive CDMO: One-stop services covering process development, scale-up, and regulatory support.